BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 01, 2010
 |  BioCentury  |  Emerging Company Profile

Homing in on HDAC6: Sidebar: Corporate Profile

Acetylon Pharmaceuticals Inc.

Winchester, Mass.

Technology:HDAC6 inhibitors

Disease focus:Cancer

Clinical status:Research

Read the full 40 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >